Create Medicines

Developer of messenger ribonucleic acid therapies for immune cell programming

placeCambridge, Massachusetts, United States calendar_todayFounded 2019 language createmedicines.com

Innovation

12 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 50 times.

YearFilings
20211
20221
20233
20241
20254
20266

Investor mix

4 investors on record; lead investors include Newpath Partners, Hatteras Venture Partners.

Investor typeCountShare
Venture capital4100%
Coming soon